Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treatment makes the prostate look more like a healthy one.

Finasteride treats hair loss but may affect prostate cancer detection.

Krill oil may help reduce prostate enlargement and growth.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Hair transplantation successfully treated hair loss in a patient with Trichorhinophalangeal syndrome.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

Dutasteride reduces DHT more effectively than finasteride.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Lack of KSR1 stops certain skin tumors in mice.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

Finasteride improves prostate cancer detection in PSA test.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.